Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation: Insights from two consecutive national surveys

Yvonne Schwammenthal, Nathan M. Bornstein, Uri Goldbourt, Silvia Koton, Roseline Schwartz, Nina Koren-Morag, Ehud Grossman, David Tanne

Research output: Contribution to journalArticle

Abstract

Background: Atrial fibrillation (AF) is a major risk factor of ischemic stroke. We tested whether the adoption of the CHADS 2 score in clinical guidelines has impacted treatment strategies for stroke prevention, and examined how AF affects stroke outcome. Methods: In the setting of two national surveys [National Acute Stroke Israeli Surveys; all patients hospitalized for stroke in Israel during February-March 2004, and March-April 2007] data of patients with and without AF were analyzed with respect to patient characteristics, use of anticoagulation, stroke severity, clinical course, and long-term outcome. Results: Of 3040 patients with acute ischemic stroke, 586 patients (19%) had a history of AF. Severe strokes on admission were significantly more frequent in patients with AF, as was the proportion of total anterior circulation strokes. Ischemic stroke associated with AF predicted poor outcome at discharge (adjusted OR 1.56; 95%CI 1.24-1.96) and higher mortality rates throughout follow-up. Among patients with a CHADS 2 score 2 prior to the index stroke and without known contraindications, 41% received anticoagulation. This proportion increased to only 62% after the index stroke, even after excluding patients with severe disability and no significant increase between 2004 and 2007 was detectable. Increasing age, in-hospital infectious complications, and unfavorable functional status at discharge were independently associated with decreased likelihood of receiving anticoagulation. Conclusions: In deviation from current recommendations and in spite of the introduction of CHADS 2 criteria, anticoagulation for stroke prevention remains underutilized, despite the particularly poor outcome of strokes associated with AF.

Original languageEnglish (US)
Pages (from-to)356-361
Number of pages6
JournalInternational Journal of Cardiology
Volume152
Issue number3
DOIs
StatePublished - Nov 3 2011
Externally publishedYes

Fingerprint

Atrial Fibrillation
Stroke
Surveys and Questionnaires
Israel
Guidelines

Keywords

  • Anticoagulation
  • Atrial fibrillation
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation : Insights from two consecutive national surveys. / Schwammenthal, Yvonne; Bornstein, Nathan M.; Goldbourt, Uri; Koton, Silvia; Schwartz, Roseline; Koren-Morag, Nina; Grossman, Ehud; Tanne, David.

In: International Journal of Cardiology, Vol. 152, No. 3, 03.11.2011, p. 356-361.

Research output: Contribution to journalArticle

Schwammenthal, Y, Bornstein, NM, Goldbourt, U, Koton, S, Schwartz, R, Koren-Morag, N, Grossman, E & Tanne, D 2011, 'Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation: Insights from two consecutive national surveys', International Journal of Cardiology, vol. 152, no. 3, pp. 356-361. https://doi.org/10.1016/j.ijcard.2010.08.005
Schwammenthal, Yvonne ; Bornstein, Nathan M. ; Goldbourt, Uri ; Koton, Silvia ; Schwartz, Roseline ; Koren-Morag, Nina ; Grossman, Ehud ; Tanne, David. / Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation : Insights from two consecutive national surveys. In: International Journal of Cardiology. 2011 ; Vol. 152, No. 3. pp. 356-361.
@article{f9dca5c44b1f4da4bd0d36ec4d1d1e86,
title = "Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation: Insights from two consecutive national surveys",
abstract = "Background: Atrial fibrillation (AF) is a major risk factor of ischemic stroke. We tested whether the adoption of the CHADS 2 score in clinical guidelines has impacted treatment strategies for stroke prevention, and examined how AF affects stroke outcome. Methods: In the setting of two national surveys [National Acute Stroke Israeli Surveys; all patients hospitalized for stroke in Israel during February-March 2004, and March-April 2007] data of patients with and without AF were analyzed with respect to patient characteristics, use of anticoagulation, stroke severity, clinical course, and long-term outcome. Results: Of 3040 patients with acute ischemic stroke, 586 patients (19{\%}) had a history of AF. Severe strokes on admission were significantly more frequent in patients with AF, as was the proportion of total anterior circulation strokes. Ischemic stroke associated with AF predicted poor outcome at discharge (adjusted OR 1.56; 95{\%}CI 1.24-1.96) and higher mortality rates throughout follow-up. Among patients with a CHADS 2 score 2 prior to the index stroke and without known contraindications, 41{\%} received anticoagulation. This proportion increased to only 62{\%} after the index stroke, even after excluding patients with severe disability and no significant increase between 2004 and 2007 was detectable. Increasing age, in-hospital infectious complications, and unfavorable functional status at discharge were independently associated with decreased likelihood of receiving anticoagulation. Conclusions: In deviation from current recommendations and in spite of the introduction of CHADS 2 criteria, anticoagulation for stroke prevention remains underutilized, despite the particularly poor outcome of strokes associated with AF.",
keywords = "Anticoagulation, Atrial fibrillation, Stroke",
author = "Yvonne Schwammenthal and Bornstein, {Nathan M.} and Uri Goldbourt and Silvia Koton and Roseline Schwartz and Nina Koren-Morag and Ehud Grossman and David Tanne",
year = "2011",
month = "11",
day = "3",
doi = "10.1016/j.ijcard.2010.08.005",
language = "English (US)",
volume = "152",
pages = "356--361",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation

T2 - Insights from two consecutive national surveys

AU - Schwammenthal, Yvonne

AU - Bornstein, Nathan M.

AU - Goldbourt, Uri

AU - Koton, Silvia

AU - Schwartz, Roseline

AU - Koren-Morag, Nina

AU - Grossman, Ehud

AU - Tanne, David

PY - 2011/11/3

Y1 - 2011/11/3

N2 - Background: Atrial fibrillation (AF) is a major risk factor of ischemic stroke. We tested whether the adoption of the CHADS 2 score in clinical guidelines has impacted treatment strategies for stroke prevention, and examined how AF affects stroke outcome. Methods: In the setting of two national surveys [National Acute Stroke Israeli Surveys; all patients hospitalized for stroke in Israel during February-March 2004, and March-April 2007] data of patients with and without AF were analyzed with respect to patient characteristics, use of anticoagulation, stroke severity, clinical course, and long-term outcome. Results: Of 3040 patients with acute ischemic stroke, 586 patients (19%) had a history of AF. Severe strokes on admission were significantly more frequent in patients with AF, as was the proportion of total anterior circulation strokes. Ischemic stroke associated with AF predicted poor outcome at discharge (adjusted OR 1.56; 95%CI 1.24-1.96) and higher mortality rates throughout follow-up. Among patients with a CHADS 2 score 2 prior to the index stroke and without known contraindications, 41% received anticoagulation. This proportion increased to only 62% after the index stroke, even after excluding patients with severe disability and no significant increase between 2004 and 2007 was detectable. Increasing age, in-hospital infectious complications, and unfavorable functional status at discharge were independently associated with decreased likelihood of receiving anticoagulation. Conclusions: In deviation from current recommendations and in spite of the introduction of CHADS 2 criteria, anticoagulation for stroke prevention remains underutilized, despite the particularly poor outcome of strokes associated with AF.

AB - Background: Atrial fibrillation (AF) is a major risk factor of ischemic stroke. We tested whether the adoption of the CHADS 2 score in clinical guidelines has impacted treatment strategies for stroke prevention, and examined how AF affects stroke outcome. Methods: In the setting of two national surveys [National Acute Stroke Israeli Surveys; all patients hospitalized for stroke in Israel during February-March 2004, and March-April 2007] data of patients with and without AF were analyzed with respect to patient characteristics, use of anticoagulation, stroke severity, clinical course, and long-term outcome. Results: Of 3040 patients with acute ischemic stroke, 586 patients (19%) had a history of AF. Severe strokes on admission were significantly more frequent in patients with AF, as was the proportion of total anterior circulation strokes. Ischemic stroke associated with AF predicted poor outcome at discharge (adjusted OR 1.56; 95%CI 1.24-1.96) and higher mortality rates throughout follow-up. Among patients with a CHADS 2 score 2 prior to the index stroke and without known contraindications, 41% received anticoagulation. This proportion increased to only 62% after the index stroke, even after excluding patients with severe disability and no significant increase between 2004 and 2007 was detectable. Increasing age, in-hospital infectious complications, and unfavorable functional status at discharge were independently associated with decreased likelihood of receiving anticoagulation. Conclusions: In deviation from current recommendations and in spite of the introduction of CHADS 2 criteria, anticoagulation for stroke prevention remains underutilized, despite the particularly poor outcome of strokes associated with AF.

KW - Anticoagulation

KW - Atrial fibrillation

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=80055035465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055035465&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2010.08.005

DO - 10.1016/j.ijcard.2010.08.005

M3 - Article

C2 - 20851475

AN - SCOPUS:80055035465

VL - 152

SP - 356

EP - 361

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 3

ER -